HIGHLIGHTS
- who: Nonhematopoietic IRAK and collaborators from the DepartmentUniversity Hospital Baselland, Liestal, Switzerland have published the research: Authorship note: SH and TJ share senior authorship. Conflict of interest: All authors except TH, BB, and DK are employees of Novartis Pharma AG. TH is currently employed by Idorsia Pharmaceuticals Ltd, in the Journal: (JOURNAL)
- what: The authors used a combination of in_vivo experimentation and functional studies of patient samples to investigate the role of IRAK1 in innate driven inflammation and more specifically, in joint inflammation.
- how: Data were analyzed using Excel XL fit 5.0 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.